- KR₩175bn
- KR₩229bn
- KR₩136bn
- 28
- 34
- 52
- 29
Annual balance sheet for Macrogen, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 57,117 | 60,839 | 47,946 | 25,312 | 42,621 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 25,371 | 23,508 | 25,242 | 28,624 | 43,181 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 96,344 | 100,216 | 90,568 | 74,034 | 112,081 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 41,189 | 51,555 | 63,275 | 77,788 | 106,159 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 287,790 | 301,176 | 280,126 | 257,818 | 329,660 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 58,045 | 76,546 | 57,572 | 57,599 | 126,077 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 89,643 | 100,534 | 100,802 | 98,627 | 168,837 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 198,147 | 200,643 | 179,323 | 159,191 | 160,823 |
Total Liabilities & Shareholders' Equity | 287,790 | 301,176 | 280,126 | 257,818 | 329,660 |
Total Common Shares Outstanding |